CARMISCIANO, LUCA
 Distribuzione geografica
Continente #
EU - Europa 3.325
AS - Asia 244
NA - Nord America 43
SA - Sud America 35
AF - Africa 8
Totale 3.655
Nazione #
IT - Italia 3.320
SG - Singapore 105
CN - Cina 72
VN - Vietnam 54
US - Stati Uniti d'America 33
BR - Brasile 21
AR - Argentina 11
MX - Messico 5
HK - Hong Kong 4
ZA - Sudafrica 4
ID - Indonesia 3
MA - Marocco 3
AT - Austria 2
DO - Repubblica Dominicana 2
IQ - Iraq 2
AL - Albania 1
CA - Canada 1
CL - Cile 1
GT - Guatemala 1
HU - Ungheria 1
IN - India 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
NP - Nepal 1
PY - Paraguay 1
RU - Federazione Russa 1
VE - Venezuela 1
Totale 3.655
Città #
Genoa 1.890
Genova 575
Vado Ligure 427
Rapallo 407
Beijing 29
Ashburn 24
Ho Chi Minh City 20
Singapore 16
Bordighera 15
Hanoi 12
Mexico City 5
Haiphong 4
Hong Kong 4
Johannesburg 3
San Jose 3
Tianjin 3
Bạc Liêu 2
Campo Largo 2
Can Tho 2
Da Nang 2
Reggio Emilia 2
São Paulo 2
Vĩnh Long 2
Agadir 1
Almaty 1
Asunción 1
Bandung 1
Berazategui 1
Bocaiúva 1
Bojonegoro 1
Brooklyn 1
Bình Dương 1
Cambé 1
Campina Grande 1
Caxias do Sul 1
Coccaglio 1
Cotia 1
Cuiabá 1
Curitiba 1
Duhok 1
Erbil 1
Ezeiza 1
Farroupilha 1
Fes 1
Formosa 1
Frutal 1
Guatemala City 1
Hưng Yên 1
Itapevi 1
José C. Paz 1
Kanpur 1
Los Angeles 1
Lấp Vò 1
Maipú 1
Manaus 1
Maturín 1
Mendoza 1
Milwaukee 1
Monte Vera 1
Nairobi 1
Nanjing 1
Nossa Senhora da Glória 1
Paulista 1
Paulínia 1
Phoenix 1
Phủ Lý 1
Quảng Ngãi 1
Rondonópolis 1
San Justo 1
Santiago 1
Santiago de los Caballeros 1
Santo Domingo 1
Sapucaia do Sul 1
Serra 1
Temperley 1
Tirana 1
Toronto 1
Tres Lomas 1
Vienna 1
Totale 3.507
Nome #
Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas 128
A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients 122
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 113
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 111
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data 108
Assessing upper limb function in Multiple Sclerosis by an engineered glove 105
Biological therapy in genital psoriasis in women 103
A multiparametric score for assessing the individual risk of severe Covid-19 among patients with Multiple Sclerosis 103
The HLA-Cw6 Dilemma: Is It Really an Outcome Predictor in Psoriasis Patients under Biologic Therapy? A Monocentric Retrospective Analysis 97
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 95
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib 95
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 95
A wide database for future studies aimed at improving early recognition of candidemia 94
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 89
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 87
Correlation Between Skin and Affected Organs in 52 Sclerodermic Patients Followed in a Diseases Management Team: Development of a Risk Prediction Model of Organ-Specific Complications 87
Full longitudinal nailfold videocapillaroscopy analysis of microvascular changes during normal pregnancy 86
Comparison of Placebos and Propensity Score Adjustment in Multiple Sclerosis Nonrandomized Studies 85
A survey of psoriasis patients on biologics during COVID-19: a single centre experience 79
Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study. 76
Engineered glove to evaluate hand disability in rheumatoid arthritis: A pilot-study 74
Frailty assessment, hip fracture and long-term clinical outcomes in older adults 71
Understanding the value of non-specific abnormal capillary dilations in presence of Raynaud's phenomenon: a detailed capillaroscopic analysis. 70
Cross-Cultural Adaptation and Validation of the Italian Version of the Observational Scale of Level of Arousal 70
Coronavirus disease 2019 in Latin American patients with multiple sclerosis 70
Oncoplastic level II volume displacement surgery for breast cancer: oncological and aesthetic outcomes 69
A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes 65
Increased serum level of N-terminal Pro-B-type natriuretic peptide in psoriatic patients: a single-center study 61
Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis 60
Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis. 60
Is ultraviolet radiation avoidance affecting bone health in melanoma patients? 58
Haploidentical Hematopoietic Cell Transplantation for Myelofibrosis in the Ruxolitinib Era 54
Dedicated 3D-T2-STIR-ZOOMit imaging improves demyelinating lesion detection in the anterior visual pathways of patients with multiple sclerosis 54
Digital work engagement among Italian neurologists 53
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 52
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 52
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 51
The MuSC-19 study: The Egyptian cohort 51
Biometry extraction and probabilistic anatomical atlas of the anterior Visual Pathway using dedicated high-resolution 3-D MRI 50
Ten daily fractions for whole breast cancer irradiation: Long term results 50
Autoimmune bullous dermatoses: should we treat the patient or the antibodies? A preliminary study 50
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 49
Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [18F]PSMA-1007 PET/CT 49
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 46
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 44
Healthy Hands: a pilot study for the prevention of chronic hand eczema in healthcare workers of an Italian University Hospital 41
Creating an automated tool for a consistent and repeatable evaluation of disability progression in clinical studies for multiple sclerosis 39
Implementation of a distance learning hand eczema prevention program for healthcare workers during the COVID-19 pandemic 36
Usefulness of the ‘two-step method’ of digital follow-up for early-stage melanoma detection in high-risk French patients: a retrospective 4-year study 36
Nonlesional Sources of Contrast Enhancement on Postgadolinium "Black-Blood" 3D T1-SPACE Images in Patients with Multiple Sclerosis 35
null 33
Validation of the Italian Version of the Rapid Geriatric Assessment in Community-Dwelling Older Adults 28
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals? 27
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis 26
Four-years experience with the preferential derivation care model for multidisciplinary care in patients with psoriasis and psoriatic arthritis 23
Signs and symptoms of Covid-19 in patients with multiple sclerosis 20
null 17
Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis 14
Totale 3.766
Categoria #
all - tutte 20.213
article - articoli 19.723
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 490
Totale 40.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202180 0 0 0 0 0 9 3 12 17 22 8 9
2021/2022352 4 2 9 38 11 22 20 77 45 38 19 67
2022/2023513 55 63 5 44 87 62 17 28 73 10 60 9
2023/2024406 15 58 10 46 33 65 24 31 16 27 26 55
2024/20251.264 69 70 27 68 135 143 124 219 53 68 167 121
2025/2026948 303 51 147 160 243 44 0 0 0 0 0 0
Totale 3.766